Wexford Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,080
Closed -$43K 233
2020
Q4
$43K Buy
+3,080
New +$43K 0.01% 200